Fibrolamellar Cancer Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 818,362 | 401,162 | 417,200 | 28.2 | 11% |
| 2012 | 863,678 | 98,758 | 764,920 | 207.7 | 38% |
| 2013 | 868,526 | 962,993 | −94,467 | 20.1 | 4% |
| 2014 | 1,113,398 | 916,340 | 197,058 | 23.8 | 5% |
| 2015 | 1,372,976 | 625,566 | 747,410 | 49.2 | 19% |
| 2016 | 1,525,060 | 2,314,245 | −789,185 | 10.2 | 8% |
| 2017 | 1,606,246 | 801,271 | 804,975 | 48.8 | 25% |
| 2018 | 1,712,900 | 1,073,035 | 639,865 | 46.6 | 23% |
| 2019 | 1,772,024 | 1,757,184 | 14,840 | 29.2 | 21% |
| 2020 | 1,841,395 | 2,741,615 | −900,220 | 15.6 | 15% |
| 2021 | 4,041,093 | 1,865,036 | 2,176,057 | 39.0 | 24% |
| 2022 | 6,076,635 | 2,563,688 | 3,512,947 | 43.4 | 19% |
| 2023 | 2,960,135 | 5,485,040 | −2,524,905 | 14.0 | 12% |
In its most recent public year (2023), this organization spent $2,524,905 more than it brought in. Its reserves stood at about 14 months of spending, down from 28.2 in 2011. Staff pay was 12% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Fibrolamellar Cancer Foundation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works